A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder

Journal of Clinical Psychiatry

Volumn 59, Issue 10, 1998, Pages 528-534

  Lepola, Ulla M ^a,i   Wade, Alan G ^b   Leinonen, Esa V ^c   Koponen, Hannu J ^d   Frazer, John ^e   Sjödin, Ingemar ^f   Penttinen, Jukka T ^g   Pedersen, Tommy ^h   Lehto, Heikki J ^h  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Clydebank Health Centre   (United Kingdom)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d Moisio Hospital   (Finland)

^e Frazer Medical Research Limited   (United Kingdom)

^f LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^g Turku Psychiatric Clinic   (Finland)

^h H LUNDBECK A S   (Denmark)

ⁱ Kuopio Psychiatric Research Clinic   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PLACEBO;

ADULT; AGORAPHOBIA; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; HUMAN; LIFE TABLE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PANIC; PATIENT COMPLIANCE; PRIORITY JOURNAL; RATING SCALE; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0031724183     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v59n1006     Document Type: Article

References (35)

1. Weissman MM, Klerman GL, Markowitz JS, et al. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med 1989;321: 1209-1214
2. Lepola U, Koponen H, Leinonen E. A naturalistic 6-year follow-up study of patients with panic disorder. Acta Psychiatr Scand 1996;93:181-183
3. Sherbourne CD, Wells KB, Judd LL, et al. Functioning and well-being of patients with panic disorder. Am J Psychiatry 1996;153:213-218
4. Mavisskalian M, Perel JM. Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Arch Gen Psychiatry 1992;49:318-323
5. Noyes R Jr, Garvey MJ, Cook BL. Follow-up study of patients with panic disorder or agoraphobia with panic attacks treated with tricyclic antide-pressants. J Affect Disord 1989;16:249-257
6. Katschnig H, Amering M, Stolk JM, et al. Long-term follow-up after a drug trial for panic disorder. Br J Psychiatry 1995;167:487-494
7. Henriksson MM, Isometsä ET, Kuoppasalmi KI, et al. Panic disorder in completed suicide. J Clin Psychiatry 1996;57:275-281
8. Boer JA, Westenberg HGM, De Leeuw AS, et al. Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine. Int Clin Psychopharmacol 1995;9(4, suppl):47-52
9. Modigh K, Westerberg K, Eriksson E. Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial. J Clin Psychopharmacol 1992;12:251-261
10. Evans L, Kenardy J, Schneider P, et al. A double blind comparison of zimeldine, imipramine and placebo: effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. Acta Psychiatr Scand 1986; 73:49-53
11. Hohen-Saric R, McLeod DR, Hipsley PA. Effect of fluvoxamine on panic disorder. J Clin Psychopharmacol 1993;13:321-326
12. Oehrberg S, Christiansen E, Behnke K, et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995;167:374-379
13. Sheehan DV, Raj BA, Trehan RR, et al. Serotonin in panic disorder and social phobia. Int Clin Psychopharmacol 1993;8(2, suppl):63-77
14. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta analysis. Int Clin Psychopharmacol 1995;10:45-49
15. Sheehan DV, Harnett-Sheehan K. The role of SSRIs in panic disorder. J Clin Psychiatry 1996;57(10, suppl):51-58
16. Sheehan DV, Dunbar CG. Treatment of panic disorder with paroxetine. In: The 2nd Novo Nordisk Symposium on Panic Disorder and OCD; December 1, 1995; Bagsvaerde, Denmark. 29-38
17. Hyttel J, Arnt J, Sanchez C. The pharmacology of citalopram. Rev Contemp Pharmacother 1995;6:271-285
18. Lepola U, Koponen H, Leinonen E, et al. Citalopram in the treatment of OCD: a pilot study. Presented at the Anxiety Disorders Association of America 16th National Conference; March 28-31, 1996; Orlando Fla.
19. Montgomery SA, Pedersen V, Tanghøj P, et al. The optimal dosing regimen for citalopram: a meta-analysis of nine placebo-controlled studies. Int Clin Psychopharmacol 1994;9(1, suppl):35-40
20. Humble M, Wistedt B. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders. Int Clin Psychopharmacol 1992;(6, suppl):21-39
21. Lepola U, Leinonen E, Turtonen J, et al. The effect of citalopram in panic disorder and agoraphobia: a pilot study. Nord J Psychiatry 1994;48:13-17
22. Wade AG, Lepola U, Koponen HJ, et al. The effect of citalopram in panic disorder: a multicentre double-blind active (clomipramine) and placebo-controlled study. Br J Psychiatry 1997;170:549-553
23. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
24. Montgomery SA, Asberg M. A new depression scale designated to be sensitive to change. Br J Psychiatry 1979;134:382-389
25. Snaith RP, Baugh SJ, Clayden AD, et al. The Clinical Anxiety Scale: an instrument derived from the Hamilton Anxiety Scale. Br J Psychiatry 1982;141:518-523
26. Sheehan DV. The Anxiety Disease. New York, NY: Charles Scribner's Sons; 1979
27. Hamilton MA. The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55
28. Maier W, Philipp M. Comparative analysis of observer depression scales. Acta Psychiatr Scand 1985;72:239-245
29. Curtis GC, Massana J, Udina C, et al. Maintenance drug therapy of panic disorder. J Psych Rev 1993;27(1, suppl):127-142
30. Schweizer E, Rickels K, Weiss S, et al. Maintenance drug treatment of panic disorder, I: results of a prospective, placebo-controlled comparison of alprazolam and imipramine. Arch Gen Psychiatry 1993;50:51-60
31. Shear MK, Leon AC, Pollack MH, et al. Pattern of placebo response. Psychopharmacol Bull 1995;31:273-278
32. Basoelu M, Marks IM, Kilic C, et al. Relationship of panic, anticipatory anxiety, agoraphobia and global improvement in panic disorder with agoraphobia treated with alprazolam and exposure. Br J Psychiatry 1994;164: 647-652
33. Cross-National Collaborative Panic Study, Second Phase Investigators. Drug treatment of panic disorder: comparative efficacy of alprazolam, imipramine and placebo. Br J Psychiatry 1992;160:191-202
34. Marks I, Greist J, Basoglu M, et al. Comment on the second phase of the Cross-National Collaborative Panic Study. Br J Psychiatry 1992;160: 202-205
35. Marks IM, Swinson RP, Basoglu M, et al. Alprazolam and exposure alone and combined in panic disorder with agoraphobia: a controlled study in London and Toronto. Br J Psychiatry 1993;162:776-787